Spironolactone Tablet, Film Coated
Product Images NDC 63629-1094

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 63629-1094). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Spironolactone 01)

FDA Label Image

Figure 1 (Spironolactone 02)

FDA Label Image

Figure 2 (Spironolactone 03)

Figure 2 (Spironolactone 03)
This appears to be a table of medical data, including information about a subgroup, creatinine, diabetes, potassium, and beta blockers. There is also a graph comparing spironolactone to placebo, with differing effectiveness over time.*
FDA Label Image

Lbl636291094

Lbl636291094
This is the label for NILD's Spironolactone Tablets, USP. Each tablet contains 100 mg of spironolactone. It should be stored at 20° to 25°C (68° to 77°F) and kept out of the reach of children. The medication should be dispensed in a tight, light-resistant container with a child-resistant closure. The label also includes the NDC number as well as information about the manufacturer (PHARMACEUTICALS) and the quantity (500 tablets).*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.